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Phosph~~ipase AZ (PLAs, EC 3. f.14 which 
hydrotyzes p~~spho~pids at the sn-2 position to 
produce a f&Q acid and B ~~sophosph~~~~~~ is 
present in almost alI cell tm and subce&&r frac- 
tions (review [l]). The activity of this enzyme has 
been correlate with various cell functions* such as 
exocytosis, platelet activatlion and prostag~~~diu 
production [2,3]. There is growing evidence that 
the enzyme inrokd is Ic~&ed in the ~41 RXSX- 
brane. ~~~b~tors of PLAz have been widely used in 
inv~tigati~~s of the role thrit cell membrane PLA2 
plays in s~~etion processes. However, since it is 
not cLear whether these inhibitors are internrrlized, 
it is not possible to determlae unequivocally that 
these ~~~t~~s act exehrsive& at the cell surface 
f2,3]. Here, we aimed at preparing a PtAz in- 
hibitor that would not filtrate into the cell, N- 
derivatives of phosphatidy~seri~e (PS) have been 
shown to inhibit PLA2 in cultured cells [4]. To 
prepare this material, we aeylated the amino 
group of PS v&h the ~~rboxy~i~ fatty acid 
(dodecandliok acid) and Hnked the free cr~boxyl 
group to a high-M, (&& 70000) dextrzm, The 
derivatized PS, after binding to the carrier, main- 
tained its abihty to inhibit PLAz. 
derivative 
30Qrmoi dod~~~dioi~ acid were added tea 
29 pmal PS dissolved in 2 ml di~~loromethan~~ 
followed by 100 mg di~ycloh~~yIc~rbodi~mid~ 
(DCCD), 0.2 ml t~~t~~larnine and 0,S mf absolute 
rn~~~~o~_ The mixture was ~~ub~~~ for 24 h at 
WC. Analysis of the products by thin-layer 
~~~~matography (TLC) in chlor~f~rm/methan~~/ 
a~~t~ne/aceti~ a~id/water (6 : 2 : 8 : 1) gave two 
spots sensitive to Phosphate spray, at the origin 
and at Rf = 0.75, identified as PS and AC-F%, 
respectbze8y. This system was used &r the purifica- 
tion of AC-PS on preparative TLC plates. The 
product was ch~~~terized by NW4 spectroscopy 
(300 MHz) in C~Cls/CD~OD (2: 1), and found to 
have a similar spectrum to PS with indication as to 
the presence of the! addition& d~~~b~xyli~ acid - 
two broadly tripkts at 2-2 ppm b~l~n~ng to the 
methyLenic protons in a-position to the carbony& 
and methylemc protons at 1.2 ppm, together with 
the proton of the fatty acid on sn-l and sn-2. The 
p~~spho~ipid content of the acylated PS was 
measured by phosphate ~te~rni~at~~~ fS].
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2.1.2. Preparation of dextran hydrazide 
10 g dextran-70 (MT 70000) dissolved in 30 ml 
water were mixed with 0.6 g sodium periodate, 
stirred for 2 h and eluted through a 100 ml column 
of Dowex l-X8-100 (chloride form) with distilled 
water. The oxidized dextran was then allowed to 
react with 300 mmol hydrazine hydrate at pH 5.0 
and then reduced by adding 50 mmol sodium 
borohydride to the reaction mixture and bringing 
the pH to 9.0. After 10 h stirring, the dextran 
hydrazide was precipitated by the addition of ab- 
solute ethanol to the reaction mixture. The 
precipitate was dissolved in 60 ml distilled water, 
dialyzed extensively against water and lyophilized. 
2.1.3. Binding of PS dodecandioyl to dextran 
hydrazide 
200 mg DCCD were added to 10 pmol AC-PS 
and 50 mg dextran hydrazide in 0.5 ml DMSO, 
followed by the addition of 200 mg DCCD, and 
stirred for 7 h at 45°C. The reaction mixture was 
then chromatographed on silica gel thin-layer 
plates in chloroform/methanol/acetone/water 
(6: 2 : 8 : 1) and tested for phosphate (using the 
phosphate spray). The only positively stained 
material was at the origin, parallel to the location 
of dextran hydrazide, which was run as a marker, 
indicating that all the acylated PS was bound to the 
macromolecule. The dextran conjugate was 
precipitated and washed repeatedly with ethanol to 
remove DMSO and DCC. The precipitate was 
dissolved in distilled water and extensively dia- 
lyzed. The compound stained positively for sugar 
and phosphate. The PS content of the precipitate 
was measured by phosphate determination [5]. 
2.2. Determination of the soluble PLA2 activity 
The fluorescent phospholipid analogue, l- 
acyl-2-(N-4-nitrobenzo-2-oxa- 1,3-diazole)amino- 
caproylphosphatidylcholine (Cs-NBD-PC), pur- 
chased from Avanti (Birmingham, AL) was used 
as a substrate for snake venom PLAz (ZVaja 
mucambiqa, Sigma). In this substrate the 
fluorophore, NBD, is bound to caproic acid (CS) at 
the sn-2 position of the phospholipid and PLA2 ac- 
tivity can be determined by monitoring the produc- 
tion of the fluorescent fatty acid (C&IBD). 
Unilamellar vesicles composed of 40 mol% 
C6-NBD-PC and 60 mol% dioleolylphosphatidyl- 
choline (DOPC) were prepared by injection of an 
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ethanolic solution into Tris buffer at pH 7.4 [6] 
and dialyzed against the buffer. The lipid vesicles 
were interacted with PLAz in the presence of 2 mM 
Ca2+ for the desired time and then subjected to 
lipid extraction and TLC as described by Sleight 
and Pagan0 [7]. The fluorescent fatty acid was ex- 
tracted from the silica gel thin layer in chloroform/ 
methanol/acid saline (1: 1: 5%) and its fluores- 
cence intensity measured [7]. 
2.3. Determination of cell-associated PLA2 
activity 
Cultured rat hepatocytes were incubated with 
serum-free Dulbecco’s modified Eagle medium 
supplemented with lipid vesicles composed of 
C&IBD-PC and DOPC as described above. The 
cell culture was then collected using rubber 
policemen and subjected to lipid extraction, TLC 
and determination of C&BD formation. 
2.4. Hepatocyte culture 
Rat liver cells were isolated by collagenase diges- 
tion and cultivated as primary monolayers on 
fibronectin coated plates as described [8]. The cells 
were used after 1 day of cultivation. 
2.5. Evaluation of the incorporation of the 
inhibitor into the lipid vesicle biiayers 
This was measured in vesicles composed of 
80 mol% C6-NBD-PC and 20 mol% DOPC. The 
NBD fluorescence is fully self-quenched and can 
be increased by dilution of the fluorescent 
phospholipid due to the insertion of other 
phospholipids [9,10]. The incorporation of the 
derivatized PS into the substrate vesicles was 
evaluated by the increase in NBD fluorescence in- 
tensity upon the addition of the inhibitor to the 
vesicle solution. 
3. RESULTS AND DISCUSSION 
The incorporation of Dex-Ac-PS into the 
C6-NBD-PC/DOPC bilayer and its effect on 
C&IBD-PC hydrolysis were examined and com- 
pared with that of the unbound AC-PS. Addition 
of AC-PS, which had been dispersed in Tris buffer 
by sonication, to C6-NBD-PC/DOPC vesicles 
(20gM total lipid), produced an immediate in- 
crease in the fluorescence intensity of NBD, in- 
dicating that AC-PS is readily incorporated into the 
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vesicle membrane. Maximal recovery of the 
fluorescence was obtained at an AC-PS/C6-NBD- 
PC ratio of 1: 1 (at about 35 mol9’o NBD). A 
similar phenomenon was observed when Dex-Ac- 
PS was added to C6-NBD-PCYDOPC vesicles, ex- 
cept that the concentration of the bound AC-PS re- 
quired for maximal fluorescence recovery was 
about &fold higher than with unbound AC-PS. 
This difference is expected since the binding of Ac- 
PS to dextran increases its dist~bution in the 
aqueous phase. 
The hydrolysis of C6-NBD-PC by snake venom 
PLAz and its inhibition by both AC-PS and Dex- 
AC-PS are presented in fig.1. Interacting PLAz 
with the Ca-NBD-PCIDOPC vesicles gave only 
two fluorescent products, as identified by TLC: 
that of C&BD-PC and C6-NBD. The fluores- 
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Fig. 1. Effect of AC-PS and Dex-Ac-PS on the hydrolysis 
of Ca-NBD-PC by snake venom PLAz. 50/tM lipid 
vesicles composed of Ca-NBD-PC/DOPC at 2: 3 molar 
ratio were incubated with 0.05 g/ml N. mocambique 
PLAz for I5 min at 37OC. The reaction mixture was then 
subjected to lipid extraction and TLC. Ca-NBD was 
extracted from the silica plate and its fhrorescence was 
measured with reference to standard curves of known 
amounts of CG-NBD. Each datum represents the mean f 
SD for 3 replications. Incubation with (0) AC-PS, (w) 
Dex-Ac-PS, (rf dextran-hydrazide (without AC-PS) in 
equivalent concentration to that of Dex-AC-PS. 
cence quantum yield in the extraction solvent was 
the same for both the substrate and product, and 
full fluorescence recovery was obtained following 
the procedure, in either the absence or the presence 
of the inhibitors. Hence, the formation of Ca-NBD 
is a direct measure of PLAz action and the in- 
hibitors do not activate alternative pathways. 
Fig.1 shows that the hydrolysis of GNBD-PC 
was practically blocked when the concentration of 
the AC-PS was about equal to that of the substrate. 
As expected from the distribution of Dex-Ac-PS 
between the aqueous phase and the lipid bilayer, 
the concentration of this inhibitor required for full 
inhibition was about IO-fold higher than that of 
the substrate. It should be noted that dextran- 
hydrazide (without the acylated PS) did not affect 
the hydrolysis of CVNBD-PC (fig.1). 
The effect of the cell-impermeable inhibitor on 
PLAz in intact cell membrane was examined using 
cultured rat hepatocytes as described in section 2. 
The cells were incubated for 1 h with C6-NBD- 
PClDOPC vesicles as described in the legend to 
table 1, then washed and examined under a 
fluorescence microscope. The fluorescent lipid was 
visualized in the plasma membranes, but not in in- 
tracellular membranes, suggesting that the 
substrate incorporates and accumulates predomi- 
nantly in the plasma membrane. Similar to the 
observation with liposomes and the soluble PLAz 
(fig-l), incubation of the cells with Ca-NBD- 
PC/DOPC vesicles produced only two fluorescent 
products: that of Ce-NBD-PC and C&BD. This 
indicates that the fluorescent fatty acid formed by 
the cell membrane PLAz does not incorporate into 
other lipids. Thus, determination of C6-NBD pro- 
duced is a measure of the cell membrane PLA2 ac- 
tivity. As shown in table 1, the hydrolysis of the in- 
corporated G-NBD-PC by the membrane PLAz is 
effectively inhibited by increasing concentration of 
Dex-Ac-PS. 
The attainment of the desired inhibitor required 
that the derivatized PS be capable of incorporation 
into the lipid bilayer and that its binding to high- 
Mr dextran would not prevent its incorporation in- 
to the membrane and not abolish its inhibitory 
capacity. These requirements are met by the 
preparation reported here. The long-chain dicar- 
boxylic fatty acid fulfills two functions: derivatiza- 
tion of the PS amino group to form a PLAz in- 
hibitor, and acting as a spacer between the PS in- 
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Table 1 
Effect of Dex-Ac-PS on the hydrolysis of Ca-NBD-PC 
by liver cell membrane PLA2 
Treatment Ca-NBD produced 
(FU/mg cell 
protein) 
Control 
+ 50pM Dex-Ac-PS 
+ 100,eM Dex-Ac-PS 
+ Dex-hydrazide (at mass 
concentration equivalent 
to IOOpM Dex-Ac-PS) 
472 f 21 
192 -t 23 
54 + 17 
463 f 27 
Cells were incubated for 1 h at 37°C with lipid vesicles 
as described in the legend to fig. 1, with increasing 
concentrations of Dex-Ac-PS. The cell culture was then 
subjected to lipid extraction, TLC and determination f 
Ca-NBD produced. Each datum represents he mean f
SD for 5 separate dishes of cultured hepatocytes. FU, 
arbitrary fluorescence units. 500 FU are equivalent to 
about 1.5 nmol Ca-NBD. The concentration of Dex-Ac- 
PS relates to the PS concentration as measured by 
phosphate determination 
corporated into the lipid bilayer and the 
macromolecular carrier in the aqueous phase, 
aimed at preventing the internalization of the in- 
hibitor into the cells. The results demonstrate that 
binding of AC-PS to dextran does not prevent the 
incorporation of the derivatized PS into lipid 
membrane and that the hydrolysis of liposomal 
Ce-NBD-PC by soluble PLA2, as well as the 
hydrolysis of Ce-NBD-PC incorporated into cell 
membrane by the membrane PLA2, is inhibited 
with increasing concentration of Dex-Ac-PS. As 
already noted, iv-derivatives of phosphatidylserine 
have been shown to incorporate into cell mem- 
brane, presumably into plasma, and inhibit 
cellular PLA2[4]. The cell-impermeable PLAz in- 
hibitor described here, which incorporates into 
lipid membranes, provides a novel means for dif- 
ferentially investigating cell surface PLA2 and its 
role in cell function. 
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